These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11767306)

  • 1. Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chromatography.
    Rivory LP; Clarke SJ; Boyer M; Bishop JF
    J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(2):135-40. PubMed ID: 11767306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Column-switching high-performance liquid chromatographic method for the determination of a thymidylate synthase inhibitor, LY231514, an investigational agent for the treatment of solid tumors, in human plasma.
    Hamilton CL; Kirkwood JA
    J Chromatogr B Biomed Appl; 1994 Apr; 654(2):297-303. PubMed ID: 8044293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer.
    Ouellet D; Periclou AP; Johnson RD; Woodworth JR; Lalonde RL
    Cancer Chemother Pharmacol; 2000; 46(3):227-34. PubMed ID: 11021740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model.
    Pestieau SR; Stuart OA; Sugarbaker PH
    Eur J Surg Oncol; 2000 Nov; 26(7):696-700. PubMed ID: 11078617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemetrexed (Alimta): a novel multitargeted antifolate agent.
    Adjei AA
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):145-56. PubMed ID: 12722874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an improved liquid chromatography-mass spectrometry method for the determination of pemetrexed in human plasma.
    Bobin-Dubigeon C; Amiand MB; Herrenknecht C; Bard JM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2451-6. PubMed ID: 19560408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Shepherd FA; Dancey J; Arnold A; Neville A; Rusthoven J; Johnson RD; Fisher B; Eisenhauer E
    Cancer; 2001 Aug; 92(3):595-600. PubMed ID: 11505404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel folate transport activity in human mesothelioma cell lines with high affinity and specificity for the new-generation antifolate, pemetrexed.
    Wang Y; Zhao R; Chattopadhyay S; Goldman ID
    Cancer Res; 2002 Nov; 62(22):6434-7. PubMed ID: 12438230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemetrexed: a multitargeted antifolate.
    Rollins KD; Lindley C
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function.
    Mita AC; Sweeney CJ; Baker SD; Goetz A; Hammond LA; Patnaik A; Tolcher AW; Villalona-Calero M; Sandler A; Chaudhuri T; Molpus K; Latz JE; Simms L; Chaudhary AK; Johnson RD; Rowinsky EK; Takimoto CH
    J Clin Oncol; 2006 Feb; 24(4):552-62. PubMed ID: 16391300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).
    Jones RJ; Twelves CJ
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):13-22. PubMed ID: 12113062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical pharmacology of pemetrexed.
    Calvert AH
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):13-7. PubMed ID: 15655931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemetrexed, a novel antifolate therapeutic alternative for cancer chemotherapy.
    Villela LR; Stanford BL; Shah SR
    Pharmacotherapy; 2006 May; 26(5):641-54. PubMed ID: 16637794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group.
    Malempati S; Nicholson HS; Reid JM; Blaney SM; Ingle AM; Krailo M; Stork LC; Melemed AS; McGovern R; Safgren S; Ames MM; Adamson PC;
    J Clin Oncol; 2007 Apr; 25(12):1505-11. PubMed ID: 17442992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple and sensitive method for the quantitative analysis of lometrexol in plasma using high-performance liquid chromatography with electrochemical detection.
    Synold TW; Xi B; Newman EM; Muggia FM; Doroshow JH
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):245-9. PubMed ID: 8891922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of the antifolate LY231514 in mice and dogs.
    Woodland JM; Barnett CJ; Dorman DE; Gruber JM; Shih C; Spangle LA; Wilson TM; Ehlhardt WJ
    Drug Metab Dispos; 1997 Jun; 25(6):693-700. PubMed ID: 9193870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates.
    Stapleton SL; Reid JM; Thompson PA; Ames MM; McGovern RM; McGuffey L; Nuchtern J; Dauser R; Blaney SM
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):461-6. PubMed ID: 16855840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the novel antifolate pemetrexed to the brain.
    Dai H; Chen Y; Elmquist WF
    J Pharmacol Exp Ther; 2005 Oct; 315(1):222-9. PubMed ID: 15987831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography.
    Stefan TL; Ingalls ST; Gerson SL; Willson JK; Hoppel CL
    J Chromatogr B Biomed Appl; 1996 Jun; 681(2):331-8. PubMed ID: 8811444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.
    Li L; Agarwal S; Elmquist WF
    Drug Metab Dispos; 2013 Mar; 41(3):659-67. PubMed ID: 23297298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.